CN Patent

CN119039292A — 基于带有钆的pcta的造影剂

Assigned to Bracco Imaging SpA · Expires 2024-11-29 · 1y expired

What this patent protects

本发明涉及基于带有钆的PCTA的造影剂。本发明涉及Gd(PCTA‑三‑谷氨酸)的RRR/SSS对映异构体对、该对的单个对映异构体、其药学上可接受的盐、其酰胺衍生物和包含至少50％的这些化合物的组合物。

USPTO Abstract

本发明涉及基于带有钆的PCTA的造影剂。本发明涉及Gd(PCTA‑三‑谷氨酸)的RRR/SSS对映异构体对、该对的单个对映异构体、其药学上可接受的盐、其酰胺衍生物和包含至少50％的这些化合物的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN119039292A
Jurisdiction
CN
Classification
—
Expires
2024-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Bracco Imaging SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.